Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K
Pulmonary Function Tests01:25

Pulmonary Function Tests

897
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
897

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salbutamol Reversal of Methacholine Induced Bronchoconstriction: Vibrating Mesh Nebulizer versus Pressurized Metered Dose Inhaler.

Journal of asthma and allergy·2026
Same author

Methacholine Challenge: Physiology, Methodology, and Clinical Interpretation.

Clinics in chest medicine·2025
Same author

What's next for direct bronchoprovocation test methods?

Expert review of respiratory medicine·2025
Same author

To stop or not to stop an asthma biologic, that is the question.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.

The European respiratory journal·2024
Same author

Respiratory System Dynamics.

Seminars in respiratory and critical care medicine·2023

Related Experiment Video

Updated: Feb 22, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.2K

Methacholine Challenge Testing: A Novel Method for Measuring PD20.

Beth E Davis1, Samuel K Simonson2, Christianne M Blais2

  • 1Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada; Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

Chest
|September 20, 2017
PubMed
Summary
This summary is machine-generated.

A new vibrating mesh nebulizer method for methacholine challenge testing offers a simple and repeatable way to measure airway hyperresponsiveness, aligning with new guidelines that recommend reporting outcomes by dose.

Keywords:
airway hyperresponsivenessasthmaguidelinesmethacholine challenge testingprovocative dose

More Related Videos

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.3K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.4K

Related Experiment Videos

Last Updated: Feb 22, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.2K
Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD
09:47

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference NPD

Published on: September 13, 2018

17.3K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.4K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Pharmacology

Background:

  • Methacholine challenge testing is crucial for diagnosing asthma and assessing airway hyperresponsiveness.
  • Traditional jet nebulizers (e.g., Wright nebulizer) have limitations, including evaporation misidentified as aerosol output and unclear availability.
  • New guidelines advocate reporting methacholine challenge results by dose, not concentration.

Purpose of the Study:

  • To develop and evaluate a novel method for methacholine challenge testing using a vibrating mesh nebulizer (Solo nebulizer).
  • To compare the performance and repeatability of the Solo nebulizer method with the standard Wright nebulizer method.
  • To ensure the developed method aligns with current guidelines recommending dose-based reporting.

Main Methods:

  • Fifteen patients with mild asthma underwent methacholine challenges using both a Solo vibrating mesh nebulizer and a Wright jet nebulizer.
  • Standard 2-minute tidal breathing was used with the Wright nebulizer.
  • A modified tidal breathing method was employed for the Solo nebulizer, nebulizing 0.5 mL of doubling methacholine concentrations at 5-minute intervals until completion.

Main Results:

  • Geometric mean doses of methacholine causing a 20% fall in FEV1 (Forced Expiratory Volume in 1 second) were similar between the Solo (96 μg) and Wright (110 μg) nebulizers.
  • Methacholine concentrations causing a 20% fall in FEV1 were significantly lower with the Solo nebulizer (0.48 mg/mL) compared to the Wright nebulizer (4.4 mg/mL).
  • Excellent repeatability (intraclass correlation coefficient > 0.92) was observed for methacholine doses within and between both nebulizer types.

Conclusions:

  • A novel, simple, and repeatable method for methacholine challenge testing using vibrating mesh nebulizer technology has been developed.
  • This new method successfully meets the latest guidelines by enabling dose-based reporting of test outcomes.
  • The vibrating mesh nebulizer offers a promising alternative for accurate and reproducible airway hyperresponsiveness assessment.